Delays in CAR T-Cell Treatment Cost Patients, Society
Delays in CAR T-cell therapy may significantly decrease gains in survival and productivity for patients with diffuse large B-cell lymphoma and pediatric acute lymphoblastic leukemia.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Legislation | Leukemia | Lymphoma | Pediatrics